The market for Penicillins and Streptomycins in Bolivia showed a fluctuation in growth over the past decade, achieving a value of USD 29.241 million in 2023. Recent years saw modest growth with year-on-year percentage increases of 4.09% in 2021, 3.92% in 2022, and 3.73% in 2023. The compound annual growth rate (CAGR) over the last five years was 6.7%, indicating steady market growth despite occasional declines in previous years. The market displayed resilience with continuous positive increments.
Future trends to watch for:
- Potential demand increase for antibiotic treatments amplifying market value.
- Technological advancements impacting drug manufacturing and distribution.
- Regulatory changes in the pharmaceutical industry that could affect market dynamics.
How does Bolivia rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 21 | 21 Switzerland | 49,944,000 | 2023 | -1.64% | -1.63% | View data |
| 22 | 22 Guatemala | 39,329,000 | 2023 | +2.5% | +2.87% | View data |
| 23 | 23 Bolivia | 29,241,000 | 2023 | +3.73% | +6.7% | |
| 24 | 24 El Salvador | 26,131,000 | 2023 | +1.87% | +2.32% | View data |
| 25 | 25 Croatia | 22,712,000 | 2023 | +1.18% | +0.84% | View data |
